Related Experiment Video
Updated: Dec 2, 2025
09:51
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
35.1K
CRISPR vs COVID-19: how can gene editing help beat a virus?
1Future Science Group, Unitec House, 2 Albert Place, Finchley Central, London, N3 1QB, UK.
Biotechniques
|November 2, 2020
Summary
CRISPR gene editing offers a powerful tool against COVID-19. This technology has been explored for diagnostics and therapeutic strategies to combat the virus.
Area of Science:
- Molecular Biology
- Genetics
- Virology
Background:
- The emergence of COVID-19 necessitated rapid development of novel countermeasures.
- CRISPR-Cas systems, renowned for precise gene editing, presented a promising avenue for research.
Discussion:
- CRISPR technology has been investigated for its potential in developing rapid diagnostic tools for SARS-CoV-2 detection.
- Applications in developing antiviral therapies, including direct targeting of the viral genome or host factors, are under exploration.
Key Insights:
- CRISPR-based diagnostics offer high sensitivity and specificity for detecting SARS-CoV-2.
- Gene editing strategies show potential for disrupting viral replication and mitigating disease severity.
Outlook:
- Further research is crucial to optimize CRISPR delivery systems and enhance therapeutic efficacy.
- CRISPR applications may play a significant role in future pandemic preparedness and response strategies.
Related Concept Videos
01:59CRISPR
55.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.7K
01:28CRISPR/Cas9 Genome Editing
1.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
02:53CRISPR and crRNAs
18.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.3K
00:49What is Genetic Engineering?
78.0K
Overview
78.0K
02:31Homologous Recombination
60.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
60.5K